We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Results 1 to 5 of 9
Most popular |Most recent


PTAB Denies Inter Partes Review of Rituxan Patents

USA - May 10 2018 The Patent Trial and Appeal Board (“the Board”) has decided not to institute inter partes review (“IPR”) on two patents owned by Biogen and Genentech...


Do Nidec Motor Corp. and Wi-Fi One Foreshadow an End to Self-Joinder in Inter Partes Review Proceedings?

USA - March 20 2018 Section 315(c) of the America Invents Act (“AIA”) provides that if the Director of the U.S. Patent and Trademark Office (“USPTO”) institutes an inter...


PTAB Finds that Tribal Sovereign Immunity Does Not Apply to Review Proceedings

USA - February 28 2018 The Patent Trial and Appeal Board (“the PTAB”) ruled last Friday, February 23, 2018, that tribal sovereign immunity does not apply to the Saint Regis...

Mark T. Rawls.


District Judge Dismisses Amgen’s Declaratory Judgment Suit Over Avastin Biosimilar

USA - February 2 2018 On February 2, 2018, U.S. District Judge George H. Wu granted Genentech’s motion to dismiss a complaint brought by Amgen in the Central District of...


Recent Decision Casts Doubt on the Fate of Tribal Sovereign Immunity at the PTAB

USA - January 9 2018 The topic of sovereign immunity was raised a number of times in inter partes review (IPR) proceedings in 2017, and it was cast into the national...